INVO Fertility (IVF) Research & Development (2020 - 2025)

INVO Fertility (IVF) has 6 years of Research & Development data on file, last reported at $127807.0 in Q2 2025.

• On a quarterly basis, Research & Development changed N/A year-over-year to $127807.0 in Q2 2025; TTM through Sep 2025 was $878250.0, a 8041.74% increase from a year earlier, with the FY2024 full-year figure at $489660.0, up 195.07% from the prior year.
• Research & Development for Q2 2025 stood at $127807.0, down from $265663.0 in the prior quarter.
• Over the last five years, Research & Development for IVF reached as high as $484780.0 in Q4 2024 and fell as low as $2668.0 in Q3 2023.
• Historically, Research & Development has averaged $113096.8 across 5 years, with a median of $73677.5 in 2022.
• Across the five-year window, Research & Development tumbled 98.48% in 2023 and surged 8106.87% in 2024, its largest moves.
• Year by year, Research & Development stood at $63756.0 in 2021, then grew by 15.81% to $73835.0 in 2022, then plunged by 92.0% to $5907.0 in 2023, then jumped by 8106.87% to $484780.0 in 2024, then sank by 73.64% to $127807.0 in 2025.
• Per Business Quant data, the three most recent Research & Development figures were $127807.0 in Q2 2025, $265663.0 in Q1 2025, and $484780.0 in Q4 2024.